Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Propionyl Eryhthromycin
1. 134-36-1
2. Propionylerythromycin
3. Erythromycin, 2'-propanoate
4. Erythromycin 2'-propionate
5. Erythromycin 2'-propanoate
6. Erythromycin, 2'-propionate
7. Erythromycin A 2'-propanoate
8. Erythromycin Propionate [usan]
9. Monopropionylerythromycin
10. Hb75cit999
11. Chebi:48913
12. [(2s,3r,4s,6r)-4-(dimethylamino)-2-[[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] Propanoate
13. Dsstox_cid_2994
14. Dsstox_rid_76822
15. Dsstox_gsid_22994
16. Erythromycin Propionate (usan)
17. (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-4-(2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-2-o-propanoyl-beta-d-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
18. Cas-134-36-1
19. Unii-hb75cit999
20. Einecs 205-140-8
21. Erythromycin-estolate
22. Spectrum_001189
23. Spectrum2_001435
24. Spectrum3_001465
25. Spectrum4_000434
26. Spectrum5_001157
27. Ncgc00094921-01
28. Erythromycinpropionate
29. Erythromycin 2''-propionate
30. Bspbio_002989
31. Kbiogr_000788
32. Kbioss_001669
33. Divk1c_000009
34. Schembl153012
35. Spbio_001570
36. Chembl2220427
37. Dtxsid9022994
38. Kbio1_000009
39. Kbio2_001669
40. Kbio2_004237
41. Kbio2_006805
42. Kbio3_002489
43. Ninds_000009
44. Erythromycin Propionate [mi]
45. Tox21_113189
46. Zinc87496183
47. Tox21_113189_1
48. Erythromycin Propionate [who-dd]
49. Idi1_000009
50. Ncgc00179619-06
51. Sbi-0051676.p002
52. D02525
53. Ab00053610_02
54. Sr-01000872590
55. Sr-01000872590-1
56. Brd-k39746403-084-01-5
57. Q27121386
58. Erythromycin, 2'-(3r*,4s*,5s*,6r*,7r*,9r*,11r*,12r*,13s*,14r*)-4-((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha-l-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((2- Propanoate-3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione
| Molecular Weight | 790.0 g/mol |
|---|---|
| Molecular Formula | C40H71NO14 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 10 |
| Exact Mass | 789.48745594 g/mol |
| Monoisotopic Mass | 789.48745594 g/mol |
| Topological Polar Surface Area | 200 Ų |
| Heavy Atom Count | 55 |
| Formal Charge | 0 |
| Complexity | 1300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Erythromycin Propionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erythromycin Propionate, including repackagers and relabelers. The FDA regulates Erythromycin Propionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erythromycin Propionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Erythromycin Propionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Erythromycin Propionate supplier is an individual or a company that provides Erythromycin Propionate active pharmaceutical ingredient (API) or Erythromycin Propionate finished formulations upon request. The Erythromycin Propionate suppliers may include Erythromycin Propionate API manufacturers, exporters, distributors and traders.
click here to find a list of Erythromycin Propionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Erythromycin Propionate written confirmation (Erythromycin Propionate WC) is an official document issued by a regulatory agency to a Erythromycin Propionate manufacturer, verifying that the manufacturing facility of a Erythromycin Propionate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Erythromycin Propionate APIs or Erythromycin Propionate finished pharmaceutical products to another nation, regulatory agencies frequently require a Erythromycin Propionate WC (written confirmation) as part of the regulatory process.
click here to find a list of Erythromycin Propionate suppliers with Written Confirmation (WC) on PharmaCompass.
Erythromycin Propionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Erythromycin Propionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Erythromycin Propionate GMP manufacturer or Erythromycin Propionate GMP API supplier for your needs.
A Erythromycin Propionate CoA (Certificate of Analysis) is a formal document that attests to Erythromycin Propionate's compliance with Erythromycin Propionate specifications and serves as a tool for batch-level quality control.
Erythromycin Propionate CoA mostly includes findings from lab analyses of a specific batch. For each Erythromycin Propionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Erythromycin Propionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Erythromycin Propionate EP), Erythromycin Propionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Erythromycin Propionate USP).
LOOKING FOR A SUPPLIER?
